(Q22241830)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16478756%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

review article

1 reference

title

The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16478756%20AND%20SRC:MED&resulttype=core&format=json

attention deficit hyperactivity disorder

16 January 2020

main subject

0 references

1 reference

2

Peter Gallagher

Peter

Gallagher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16478756%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Heather Ashton

1

Heather

Ashton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16478756%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Brian Moore

series ordinal

3

author given names

Brian

author last names

Moore

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16478756%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

language of work or name

English

0 references

publication date

14 February 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16478756%20AND%20SRC:MED&resulttype=core&format=json

Journal of Psychopharmacology

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16478756%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16478756%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16478756%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

602-610

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16478756%20AND%20SRC:MED&resulttype=core&format=json

Nervous habits and stereotyped behaviors in preschool children.

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Stimulants and the developing brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Altering the course of neurodevelopment: a framework for understanding the enduring effects of psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

A double-blind, placebo-controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Adolescent exposure to methylphenidate alters the activity of rat midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Enduring behavioral effects of early exposure to methylphenidate in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Use of stimulants for attention deficit hyperactivity disorder: FOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Dopamine transporter density in patients with attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Comparative efficacy of Adderall and methylphenidate in attention-deficit/hyperactivity disorder: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Molecular genetics of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Brain development during childhood and adolescence: a longitudinal MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Effect of amphetamine-induced dopamine release on radiotracer binding to D1 and D2 receptors in rat brain striatal slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Prevalence and characteristics of adolescents patients with co-occurring ADHD and substance dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Hallucinations during methylphenidate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Development of human brain functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Methylphenidate and growth in hyperactive children. A controlled withdrawal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Abuse and toxicity of methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Poison centers' experience with methylphenidate abuse in pre-teens and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Diagnostic controversies in adult attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

The dopamine transporter and attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Early developmental exposure to methylphenidate reduces cocaine-induced potentiation of brain stimulation reward in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Weekend holidays during methylphenidate use in ADHD children: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Selegiline in comparison with methylphenidate in attention deficit hyperactivity disorder children and adolescents in a double-blind, randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Maternal use of dextroamphetamine and growth of the fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

A placebo-controlled study of lofexidine in the treatment of children with tic disorders and attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

A dose-ranging study of a methylphenidate transdermal system in children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

The neuropsychopharmacology of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Growth on stimulant medication; clarifying the confusion: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Six-week open-label reboxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Pharmacological management of attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Depression and psychotic regression following prolonged methylphenidate use and withdrawal: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Treatment of ADHD when tolerance to methylphenidate develops

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Can stimulant rebound mimic pediatric bipolar disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Cerebral arteritis following methylphenidate use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Stuttering priapism associated with withdrawal from sustained-release methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Effect of methylphenidate on executive functioning in adults with attention-deficit/hyperactivity disorder: normalization of behavior but not related brain activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Psychological heterogeneity in AD/HD--a dual pathway model of behaviour and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Psychosis associated with prescribed dexamphetamine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Nonstimulant treatment of adult attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

An adolescent who abruptly stops his medication for attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Reinforcing effects of methylphenidate: influence of dose and behavioral demands following drug administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Acute ischemia after intraarterial drug injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Pay attention: ritalin acts much like cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

What are the long-term effects of methylphenidate treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Attention-Deficit/Hyperactivity Disorder in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

7 January 2021

Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

7 January 2021

Acute psychosis associated with therapeutic use of dextroamphetamine

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

7 January 2021

Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: an interim analysis.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106061710

7 January 2021

Identifiers

DOI

10.1177/0269881106061710

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16478756%20AND%20SRC:MED&resulttype=core&format=json

release_llofsknm3bad3pxbehrfulu2a4

16 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/llofsknm3bad3pxbehrfulu2a4

24 November 2022

mapped directly with Wikidata item

1 reference